Galderma Group AG-Unspon ADRGALDY
13F holders, Q1 2026 (March 31)3holders −1
0new positions
1sold out
$38.92avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Galderma Group AG-Unspon ADR (GALDY) in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($931K), PNC Financial Services Group, Inc. ($79K) and Salomon & Ludwin, LLC ($41K).
- Company
- Galderma Group AG-Unspon ADR
- CUSIP
- 36321W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3K |
All 13F filers, Q4 2025 → Q1 2026: 3,648 shares bought and 70 shares sold, net +3,578 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | Add +13.0% | 23,942 | $931K |
| PNC Financial Services Group, Inc. | 0.00% | Add +4.6% | 2,039 | $79K |
| Salomon & Ludwin, LLC | 0.00% | Add +343.2% | 1,046 | $41K |
"% of holder's portfolio" is GALDY's weight in each manager's 13F, not the share of Galderma Group AG-Unspon ADR the manager owns.